Density functional study on structures, stabilities, and electronic properties of size-selected Pd n Si q (n = 1–7 and q = 0, +1, −1) clusters

The density functional theory (DFT) calculations within the framework of generalized gradient approximation have been employed to systematically investigate the geometrical structures, stabilities, and electronic properties of Pd _n Si ^q (n = 1–7 and q = 0, +1, ?1) clusters and compared them with the pure ${\text{Pd}}_{n + 1}^{q}$ (n = 1–7 and q = 0, +1, ?1) clusters for illustrating the effect of doping Si atom into palladium nanoclusters. The most stable configurations adopt a three-dimensional structure for both pure and Si-doped palladium clusters at n = 3–7. As a result of doping, the Pd _n Si clusters adopt different geometries as compared to that of Pd _n+1. A careful analysis of the binding energies per atom, fragmentation energies, second-order difference of energies, and HOMO–LUMO energy gaps as a function of cluster size shows that the clusters ${\text{Pd}}_{4}^{ + }$ , ${\text{Pd}}_{4}$ , ${\text{Pd}}_{8}^{ - }$ , ${\text{Pd}}_{5} {\text{Si}}^{0, + , - }$ , and ${\text{Pd}}_{7} {\text{Si}}^{0, + , - }$ possess relatively higher stability. There is enhancement in the stabilities of palladium frameworks due to doping with an impurity atom. In addition, the charge transfer has been analyzed to understand the effect of doped atom and compared further.     

Mixed-ligand metal complexes containing an ONS Schiff base and imidazole/benzimidazole ligands: synthesis,characterization, crystallography and biological activity

Salicylaldehyde-4-methylthiosemicarbazone (H₂MTSali) has been prepared via the condensation reaction of 4-methyl-3-thiosemicarbazide and salicylaldehyde. Four new mixed-ligand copper(II) and nickel(II) complexes with a general formula [M(MTSali)L] (M = Cu²⁺ or Ni²⁺; L = co-ligand) were synthesized, where L is either imidazole (im) or benzimidazole (bzim). The Schiff base and its mixed-ligand complexes were characterized by IR and UV/Vis spectroscopy, and the complexes by molar conductivity and magnetic susceptibility measurements. The spectroscopic data indicated that the Schiff base behaves as a tridentate ONS donor ligand coordinating via the phenoxide-oxygen, azomethine-nitrogen, and thiolate-sulphur atoms. Magnetic data indicate a square planar environment for the nickel(II) complexes while molar conductance values indicate that the metal complexes are essentially non-electrolytes in DMSO solution. X-ray crystallography shows Cu(MTSali)bzim (1) and Ni(MTSali)bzim (3) to be isostructural, with the metal(II) ions being coordinated by a N₂OS donor set that defines an approximate square planar geometry; in both cases, the benzimidazole is splayed with respect to the coordination plane. The copper(II) complexes were active against MDA-MB-231 and MCF-7 breast cancer cell lines, more so than H₂MTSali, whereas the nickel(II) complexes were inactive.     

Formation and Stability of Binary Complexes of Divalent Ecotoxic Ions (Ni, Cu, Zn, Cd, Pb) with Biodegradable Aminopolycarboxylate Chelants (dl-2-(2-Carboxymethyl)Nitrilotriacetic Acid, GLDA, and 3-Hydroxy-2,2′-Iminodisuccinic Acid, HIDS) in Aqueous Solutions

The protonation and complex formation equilibria of two biodegradable aminopolycarboxylate chelants {dl-2-(2-carboxymethyl)nitrilotriacetic acid (GLDA) and 3-hydroxy-2,2??-iminodisuccinic acid (HIDS)} with Ni²⁺, Cu²⁺, Zn²⁺, Cd²⁺ and Pb²⁺ ions were investigated using the potentiometric method at a constant ionic strength of I?=?0.10?mol·dm^?3 (KCl) in aqueous solutions at 25?±?0.1?°C. The stability constants of the proton?Cchelant and metal?Cchelant species for each metal ion were determined, and the concentration distributions of various complex species in solution were evaluated for each ion. The stability constants (log₁₀ K _ML) of the complexes containing Ni²⁺, Cu²⁺, Zn²⁺, Cd²⁺ and Pb²⁺ ions followed the identical order of log₁₀ K _CuL?>?log₁₀ K _NiL?>?log₁₀ K _PbL?>?log₁₀ K _ZnL?>?log₁₀ K _CdL for either GLDA (13.03?>?12.74?>?11.60?>?11.52?>?10.31) or HIDS (12.63?>?11.30?>?10.21?>?9.76?>?7.58). In each case, the constants obtained for metal?CGLDA complexes were larger than the corresponding constants for metal?CHIDS complexes. The conditional stability constants (log₁₀ $ K_{\text{ML}}^{'} $ ) of the metal?Cchelant complexes containing GLDA and HIDS were calculated in terms of pH, and compared with the stability constants for EDTA and other biodegradable chelants.     

The fluorescence properties of luteolines

The fluorescence properties of luteoline and its possible methyl ethers (a representative class of naturally occurring flavonoids) were investigated, together with the effect of diagnostic shift reagents such as sulfuric acid, aluminium trichloride, and borax. The results demonstrate that fluorimetry is a suitable tool for the identification and structure elucidation of minute samples of flavones, in particular if combined with absorption spectrometry. ThepK _a values of all trimethylethers were determined for the ground and first excited singlet states and related to the effects of basic reagents.

---

Die Fluoreszenzeigenschaften der Luteoline

Zusammenfassung Es wurden die Fluoreszenzeigenschaften der Luteoline (einer repräsentativen Klasse von natürlich vorkommenden Flavonoiden) sowie der Effekt diagnostischer Verschiebungsreagentien wie z. B. Schwefelsäure, Aluminiumtrichlorid und Borax untersucht. Die Ergebnisse zeigen, daß die Fluorimetrie eine geeignete Methode zur Identifikation und Strukturaufklärung auch geringster Probenmengen sein kann, besonders in Kombination mit Absorptionsmessungen. DiepK _s -Werte aller möglichen Trimethylether wurden für Grund- und ersten angeregten Zustand bestimmt und zu den Effekten der basischen Reagentien in Bezug gebracht.

     

Synthesis,spectroscopic and crystal structure analysis of a compound with pharmocophoric substituent: 2-cyclohexyl-6-(2-oxo-2H-chromen-3-yl)- imidazo[2,1-b][1,3,4]thiadiazole-5-carbaldehyde

Imidazo[2,1-b][1,3,4] thiadiazole derivatives are significant for their various pharmacological properties. This paper reports the synthesis and structure of one of them, 2-cyclohexyl-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-carbaldehyde. The compound crystallizes in the monoclinic space group P2₁/c with a=17.316(3)?, b=6.5420(9)?, c =17.056(3)?, β=112.909(2)°, V=1779.7(4)?³, z=4. The, Imidazo[2,1-b][1,3,4] thiadiazole and the coumarin ring systems are each planar but inclined at an angle of 48.14(2)° towards each other. The crystal structure is stabilized by C–H … O interactions.     

Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders

Cardiovascular disorders (CVDs) are the leading risk factor for death worldwide, and research into the processes and treatment regimens has received a lot of attention. Tilianin is a flavonoid glycoside that can be found in a wide range of medicinal plants and is most commonly obtained from Dracocephalum moldavica. Due to its extensive range of biological actions, it has become a well-known molecule in recent years. In particular, numerous studies have shown that tilianin has cardioprotective properties against CVDs. Hence, this review summarises tilianin’s preclinical research in CVDs, as well as its mechanism of action and opportunities in future drug development. The physicochemical and drug-likeness properties, as well as the toxicity profile, were also highlighted. Tilianin can be a natural lead molecule in the therapy of CVDs such as coronary heart disease, angina pectoris, hypertension, and myocardial ischemia, according to scientific evidence. Free radical scavenging, inflammation control, mitochondrial function regulation, and related signalling pathways are all thought to play a role in tilianin’s cardioprotective actions. Finally, we discuss tilianin-derived compounds, as well as the limitations and opportunities of using tilianin as a lead molecule in drug development for CVDs. Overall, the scientific evidence presented in this review supports that tilianin and its derivatives could be used as a lead molecule in CVD drug development initiatives.     

Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review

Cancer is a group of disorders characterized by uncontrolled cell growth that affects around 11 million people each year globally. Nanocarrier-based systems are extensively used in cancer imaging, diagnostics as well as therapeutics; owing to their promising features and potential to augment therapeutic efficacy. The focal point of research remains to develop new-fangled smart nanocarriers that can selectively respond to cancer-specific conditions and deliver medications to target cells efficiently. Nanocarriers deliver loaded therapeutic cargos to the tumour site either in a passive or active mode, with the least drug elimination from the drug delivery systems. This review chiefly focuses on current advances allied to smart nanocarriers such as dendrimers, liposomes, mesoporous silica nanoparticles, quantum dots, micelles, superparamagnetic iron-oxide nanoparticles, gold nanoparticles and carbon nanotubes, to list a few. Exhaustive discussion on crucial topics like drug targeting, surface decorated smart-nanocarriers and stimuli-responsive cancer nanotherapeutics responding to temperature, enzyme, pH and redox stimuli have been covered.     

The electronic structure of the isoelectronic, square-planar complexes [FeII(L)2]2- and [CoIII(L Bu)2]- (L2- and (L Bu)2-=benzene-1,2-dithiolates): an experimental and density functional theoretical study

The electronic structures of two formally isoelectronic transition-metal dithiolato complexes [Fe(L)2]2- (1) and [Co(L Bu)2]1- (2) both possessing a spin triplet ground state (St=1) have been investigated by various spectroscopic and density functional methods; H2L Bu represents the pro-ligand 3,5-di-tert-butylbenzene-1,2-dithiol and H2L is the corresponding unsubstituted benzene-1,2-dithiol. An axial zero-field splitting (D) of +32 cm(-1) for 2 has been measured independently by SQUID magnetometry, far-infrared absorption, and variable-temperature and variable-field (VTVH) magnetic circular dichroism spectroscopies. A similar D value of +28 cm(-1) is obtained for 1 on the basis of VTVH SQUID measurements. The absorption spectra of 1 and 2 are found, however, to be very different. Complex 1 is light yellow in color with no intense transition in the visible region, whereas 2 is deep blue. DFT calculations establish that the electronic structures of the [Fe(L)2](2-) and [Co(L)2]1- anions are very different and explain the observed differences in their absorption spectra. On the basis of these spectroscopic and theoretical analyses, 1 is best described as containing an intermediate spin FeII ion, whereas for the corresponding cobalt complex, oxidation states describing a d6 (CoIII) or d7 (CoII) electron configuration cannot be unambiguously assigned. The physical origin of the large zero-field splitting in both 1 and 2 is found to be due to the presence of low-energy spin-conserved d-d excitations which lead to a large Dzz through efficient spin-orbit coupling. Differential covalency effects appear to be of limited importance for this property.     

Synthesis,Spectroscopic and Crystal Structure Analysis of <Emphasis Type="Italic">N</Emphasis>-[imidazolidin-2-ylidene]-5-(thien-2-yl)[1,3,4]thiadiazole-2-amine

The crystal structure of the title compound has been determined. The compound crystallizes in the monoclinic space group P2₁/c with a = 5.9885(2) Å, b = 14.7345(4) Å, c = 12.3719(4) Å, β = 96.655(5)°, V = 1084.31(8) Å³, z = 4. An intramolecular N–H···N hydrogen bond forms a pseudo-six-membered ring with graph set S ¹ ₁(6). The crystal structure is stabilized by intermolecular interactions of the type N–H···N and C–H···N. The packing motifs in accordance with Etter’s analysis are R ² ₂(8) corresponding to N–H···N dimer and that generated by the chain is C(7).